Related Experiment Video
Updated: Aug 15, 2025
07:57
Protocols for Vaginal Inoculation and Sample Collection in the Experimental Mouse Model of Candida vaginitis
Published on: December 8, 2011
33.4K
Clinical and morphopathological assay in vulvovaginal candidiasis
Maria Magdalena Manolea1, Anca Maria Istrate-Ofiţeru, Maria Sidonia Săndulescu
1Department of Histology, Department of Obstetrics and Gynecology, University of Medicine and Pharmacy of Craiova, Romania; ancaofiteru92@yahoo.com; ssidoniam@yahoo.com.
Summary
This study compared symptomatic and asymptomatic vulvovaginal candidiasis in pregnant and non-pregnant patients. Local Nystatin treatment proved safe and effective for both groups, including those with recurrent infections.
Area of Science:
- Gynecology
- Infectious Diseases
- Dermatology
Background:
- Vulvovaginal candidiasis (VVC) involves inflammation of vaginal and vulvar epithelium due to Candida species.
- Understanding VVC in pregnant versus non-pregnant individuals, and symptomatic versus asymptomatic cases, is crucial for effective management.
Purpose of the Study:
- To compare clinical, microbiological, and histopathological features of VVC in pregnant and non-pregnant patients.
- To correlate microscopic findings with symptoms prior to Nystatin treatment.
- To evaluate the efficacy and safety of local Nystatin for VVC.
Main Methods:
- Retrospective analysis of 166 pregnant or non-pregnant patients treated for vaginitis between 2021-2022.
- Histopathological examination of vaginal mucosa and subepithelial connective tissue.
- Correlation of microscopic inflammatory markers with clinical symptoms.
Main Results:
- Symptomatic VVC cases showed higher inflammatory and vascular cellularity in the subepithelial connective tissue compared to asymptomatic cases.
- Asymptomatic patients had significantly fewer inflammatory cells and blood vessels beneath the epithelium pre-treatment.
- Local Nystatin treatment demonstrated benefits and safety in both pregnant and non-pregnant patients.
Conclusions:
- Microscopic inflammatory markers correlate with VVC symptom severity.
- Local Nystatin is a beneficial and safe treatment option for VVC.
- Nystatin is a suitable alternative for recurrent vulvovaginal candidiasis management.
